SEC Comment Letter 0000000000-23-005084 to NANOVIRICIDES, INC. (NNVC) (CIK 0001379006) (NNVC)
NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)
Date: May 12, 2023 · CIK: 0001379006 · Accession: 0000000000-23-005084
AI Filing Summary & Sentiment
File numbers found in text: 333-271706
Letter
United States securities and exchange commission logo May 12, 2023 Dr. Anil Diwan President and Chairman NANOVIRICIDES, INC. 1 Controls Drive Shelton, Connecticut 06484 Re:NANOVIRICIDES, INC. Registration Statement on Form S-3 Filed May 5, 2023 File No. 333-271706 Dear Dr. Anil Diwan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Cindy Polynice at 202-551-8707 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Peter Campitiello, Esq.
Show Raw Text
United States securities and exchange commission logo
May 12, 2023
Dr. Anil Diwan
President and Chairman
NANOVIRICIDES, INC.
1 Controls Drive
Shelton, Connecticut 06484
Re:NANOVIRICIDES, INC.
Registration Statement on Form S-3
Filed May 5, 2023
File No. 333-271706
Dear Dr. Anil Diwan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Cindy Polynice at 202-551-8707 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Peter Campitiello, Esq.